{"name":"Mediphase Venture Partners","permalink":"mediphase-venture-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/mediphase-venture-partners","homepage_url":"http://www.mediphaseventure.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"617-332-3408","description":"Venture capital Firm","email_address":"info@mediphaseventure.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Thu Jan 01 05:16:52 UTC 2009","updated_at":"Tue May 26 07:09:32 UTC 2009","overview":"<p>Mediphase Venture Partners is a venture capital firm focusing on health care/life sciences companies. They seek rapidly growing companies with outstanding market opportunities. They are active investors, usually joining the Boards of their portfolio companies and working closely with management to promote rapid growth. The fund managers bring an unusual combination of technical experience, operating experience, and investment experience, which can be critical to the success of an early stage company. </p>","image":{"available_sizes":[[[150,77],"assets/images/resized/0003/2809/32809v1-max-150x150.png"],[[170,88],"assets/images/resized/0003/2809/32809v1-max-250x250.png"],[[170,88],"assets/images/resized/0003/2809/32809v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"3 Newton Executive Park","address2":"(2223 Washington Street), Suite 104","zip_code":"02462","city":"Newton","state_code":"MA","country_code":"USA","latitude":42.3264573,"longitude":-71.2565189}],"relationships":[{"is_past":false,"title":"Founding Partner","person":{"first_name":"Lawrence","last_name":"G. Miller","permalink":"lawrence-g-miller","image":null}},{"is_past":false,"title":"Financial Consultant","person":{"first_name":"David","last_name":"C. Lubner","permalink":"david-c-lubner","image":null}},{"is_past":false,"title":"Founding Partner","person":{"first_name":"Paul A.","last_name":"Howard","permalink":"paul-a-howard","image":null}},{"is_past":false,"title":"Operations Manager","person":{"first_name":"Amanda","last_name":"Cobb","permalink":"amanda-cobb","image":null}}],"investments":[{"funding_round":{"round_code":"a","source_url":"http://www.equityhelpdesk.com/PrivateEquity/Tetraphase_Adds_15_Million","source_description":"Equity Help Desk","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":7,"company":{"name":"Tetraphase Pharmaceuticals","permalink":"tetraphase-pharmaceuticals","image":{"available_sizes":[[[150,25],"assets/images/resized/0003/2808/32808v1-max-150x150.png"],[[250,41],"assets/images/resized/0003/2808/32808v1-max-250x250.png"],[[251,42],"assets/images/resized/0003/2808/32808v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://venturebeat.com/2007/10/29/amgen-relypsa-and-the-art-of-the-biotech-spinout-startup-restart/","source_description":"Amgen, Relypsa and the art of the biotech-spinout-startup-restart","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":29,"company":{"name":"Relypsa","permalink":"relypsa","image":{"available_sizes":[[[150,79],"assets/images/resized/0003/7781/37781v1-max-150x150.png"],[[250,132],"assets/images/resized/0003/7781/37781v1-max-250x250.png"],[[292,155],"assets/images/resized/0003/7781/37781v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"","source_description":"Capital Funding Report","raised_amount":37000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":4,"funded_day":30,"company":{"name":"Concert Pharmaceuticals","permalink":"concert-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0004/5452/45452v1-max-150x150.jpg"],[[180,52],"assets/images/resized/0004/5452/45452v1-max-250x250.jpg"],[[180,52],"assets/images/resized/0004/5452/45452v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.patientkeeper.com/news_events/press_release.html?id=187","source_description":"PatientKeeper Closes $8 Million Financing to Support Continued Rapid Growth","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":6,"funded_day":14,"company":{"name":"PatientKeeper","permalink":"patientkeeper","image":{"available_sizes":[[[150,29],"assets/images/resized/0003/1129/31129v2-max-150x150.jpg"],[[250,48],"assets/images/resized/0003/1129/31129v2-max-250x250.jpg"],[[256,50],"assets/images/resized/0003/1129/31129v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/tetraphase-hauls-45m-c-round-back-antibiotic-work/2010-06-01?utm_medium=rss&utm_source=rss","source_description":"Tetraphase hauls in $45M C round to back antibiotic work","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":1,"company":{"name":"Tetraphase Pharmaceuticals","permalink":"tetraphase-pharmaceuticals","image":{"available_sizes":[[[150,25],"assets/images/resized/0003/2808/32808v1-max-150x150.png"],[[250,41],"assets/images/resized/0003/2808/32808v1-max-250x250.png"],[[251,42],"assets/images/resized/0003/2808/32808v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/09/relypsa-raises-70m-in-series-b.html","source_description":"Relypsa Raises $70M in Series B Financing","raised_amount":70000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":13,"company":{"name":"Relypsa","permalink":"relypsa","image":{"available_sizes":[[[150,79],"assets/images/resized/0003/7781/37781v1-max-150x150.png"],[[250,132],"assets/images/resized/0003/7781/37781v1-max-250x250.png"],[[292,155],"assets/images/resized/0003/7781/37781v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}